110 related articles for article (PubMed ID: 15286456)
1. Genetic association of CYP46 and risk for Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
[TBL] [Abstract][Full Text] [Related]
2. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
[TBL] [Abstract][Full Text] [Related]
4. CYP46: a risk factor for Alzheimer's disease or a coincidence?
Golanska E; Hulas-Bigoszewska K; Wojcik I; Rieske P; Styczynska M; Peplonska B; Pfeffer A; Luczywek E; Wasiak B; Gabryelewicz T; Religa D; Chodakowska-Zebrowska M; Barcikowska M; Sobow T; Liberski PP
Neurosci Lett; 2005 Jul 22-29; 383(1-2):105-8. PubMed ID: 15936520
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.
Tedde A; Rotondi M; Cellini E; Bagnoli S; Muratore L; Nacmias B; Sorbi S
Neurobiol Aging; 2006 May; 27(5):773.e1-773.e3. PubMed ID: 16055229
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
7. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.
Wang B; Zhang C; Zheng W; Lu Z; Zheng C; Yang Z; Wang L; Jin F
Neurosci Lett; 2004 Oct; 369(2):104-7. PubMed ID: 15450677
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.
Desai P; DeKosky ST; Kamboh MI
Neurosci Lett; 2002 Aug; 328(1):9-12. PubMed ID: 12123847
[TBL] [Abstract][Full Text] [Related]
9. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.
Papassotiropoulos A; Streffer JR; Tsolaki M; Schmid S; Thal D; Nicosia F; Iakovidou V; Maddalena A; Lütjohann D; Ghebremedhin E; Hegi T; Pasch T; Träxler M; Brühl A; Benussi L; Binetti G; Braak H; Nitsch RM; Hock C
Arch Neurol; 2003 Jan; 60(1):29-35. PubMed ID: 12533085
[TBL] [Abstract][Full Text] [Related]
10. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
11. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
Chalmers KA; Culpan D; Kehoe PG; Wilcock GK; Hughes A; Love S
Neuroreport; 2004 Jan; 15(1):95-8. PubMed ID: 15106838
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.
Helisalmi S; Vepsäläinen S; Koivisto AM; Mannermaa A; Iivonen S; Hiltunen M; Kiviniemi V; Soininen H
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):421-2. PubMed ID: 16484661
[No Abstract] [Full Text] [Related]
13. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.
Kabbara A; Payet N; Cottel D; Frigard B; Amouyel P; Lambert JC
Neurosci Lett; 2004 Jun; 363(2):139-43. PubMed ID: 15172102
[TBL] [Abstract][Full Text] [Related]
14. CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.
Juhász A; Rimanóczy A; Boda K; Vincze G; Szlávik G; Zana M; Bjelik A; Pákáski M; Bódi N; Palotás A; Janka Z; Kálmán J
Neurochem Res; 2005 Aug; 30(8):943-8. PubMed ID: 16258842
[TBL] [Abstract][Full Text] [Related]
15. Cyp46 polymorphisms in Alzheimer's disease: a review.
Garcia AN; Muniz MT; Souza e Silva HR; da Silva HA; Athayde-Junior L
J Mol Neurosci; 2009 Nov; 39(3):342-5. PubMed ID: 19705089
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease].
Wang F; Jia JP
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(9):614-8. PubMed ID: 17550732
[TBL] [Abstract][Full Text] [Related]
17. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
Vega GL; Weiner MF
J Mol Neurosci; 2007 Sep; 33(1):51-5. PubMed ID: 17901546
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese.
Wang F; Jia J
Brain Res; 2007 May; 1147():34-8. PubMed ID: 17335784
[TBL] [Abstract][Full Text] [Related]
19. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
[TBL] [Abstract][Full Text] [Related]
20. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
